Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
First Wave Bio (FWBI)
NASDAQ:FWBI
Holding FWBI?
Track your performance easily
FWBI Stock Chart & Stats
Day’s Range$2.83 - $3.05
52-Week Range― - ―
Previous Close$2.83
Volume56.52K
Average Volume (3M)N/A
Market Cap
$7.38M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Aug 13, 2019EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$36.00Price Target Upside1116.22% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
First Wave Bio News
PremiumCompany Announcements
First Wave Bio Announces New Ticker Symbol and Corporate Identity
PremiumCompany Announcements
First Wave Bio Secures Funding Through Equity and Warrant Sales
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
1.09% Other Institutional Investors
98.91% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
FWBI FAQ
What was First Wave Bio’s price range in the past 12 months?
Currently, no data Available
What is First Wave Bio’s market cap?
Currently, no data Available
When is First Wave Bio’s upcoming earnings report date?
First Wave Bio’s upcoming earnings report date is Aug 13, 2019 which is 1947 days ago.
How were First Wave Bio’s earnings last quarter?
Currently, no data Available
Is First Wave Bio overvalued?
According to Wall Street analysts First Wave Bio’s price is currently Undervalued.
Does First Wave Bio pay dividends?
First Wave Bio does not currently pay dividends.
What is First Wave Bio’s EPS estimate?
First Wave Bio’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does First Wave Bio have?
Currently, no data Available
What happened to First Wave Bio’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of First Wave Bio?
Currently, no hedge funds are holding shares in FWBI
---
First Wave Bio Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$36.00 (1116.22% Upside)
$36.00 (1116.22% Upside)
Blogger Sentiment
Bullish
FWBI Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $16.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▲ 0.7%
Last 30 Days ▼ 1.7%
Last 30 Days ▼ 1.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-94.39%
12-Months-Change
Fundamentals
Return on Equity
-15.28%
Trailing 12-Months
Asset Growth
1546.81%
Trailing 12-Months
Company Description
First Wave Bio
AzurRx BioPharma, Inc. engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. It focuses on MS1819-SD, and B-Lactamase program products. The company was founded on January 30, 2014 and is headquartered in Brooklyn, NY.
---
FWBI Stock 12 Month Forecast
Average Price Target
$36.00
▲(1116.22% Upside)
Technical Analysis
Best Analysts Covering FWBI
1 Year
1 Year Success Rate
1/7 ratings generated profit
1 Year Average Return
-50.20%
reiterated a buy rating 9 months ago
Copying Jonathan Aschoff's trades and holding each position for 1 Year would result in 14.29% of your transactions generating a profit, with an average return of -50.20% per trade.
---